Commentary · 21 Feb 2026
Conference abstractPublished 17 Sep 2018
Ganplex and Kimera-Test: Biotechnological screening tools designed identify human cancer-related virus and SNPs in non-invasive samples
Hakken Enterprise S.A. de C.V., Mexico University of Veracruz, Mexico Universidad Nacional Autonoma de Mexico, Mexico
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Most efforts of allopathic medicine are directed to treat diseases. This path has proved to be costly when chronic diseases, such as cancer and its associated viral co-morbidities, need to be treated and monitored in the long term. Hence, the development of prevention-oriented medicine may reduce the magnitude of the financial burden associated with practicing remedy-based medicine. GanplexTM and Kimera-TestTM, the prime products of Hakken Enterprise, were then conceived to identify individuals with high genetic risk of developing cancer before the disease becomes symptomatic. GanplexTM and Kimera-TestTM take advantage of DNA extracted from saliva and urine samples to identify cancer-related viruses and SNPs through multiplex assays in a single reaction. At the current stage of development, both assays identify cancer-related SNPs and the viral sequences with a sensitivity, specificity, and confidence higher than those reported for Sangerâ??s sequencing. Both assays require small DNA quantities to begin with and no purification of PCR products prior hybridization. This shortens to approximately 7 hours the time to provide a result. Hence, GanplexTM and Kimera-TestTM are biotechnological tools that provide the genetic information needed to identify individuals under risk of developing cancer, a circumstance that would help in personalizing cancer preventing protocols and introducing precision medicine into everydayâ??s life. This work was financed by CONACyT (Grant No. 250884, 230066).
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Gisela Aguirre”
- BylineArticles whose byline prints “Delgado Pastelin L”
- BylineArticles whose byline prints “Flores-Fortis M”
- BylineArticles whose byline prints “Flores-Bahena C”
- BylineArticles whose byline prints “Medina-Garcia CV”
- BylineArticles whose byline prints “Medina-Soriano S”
- BylineArticles whose byline prints “Zepeda-Hernandez R”
- BylineArticles whose byline prints “Gutierrez-Ospina”
